US surpasses 700,000 Covid-19 deaths

 The US surpassed 700,000 deaths from Covid-19 on Friday, 108 days after the country reached 600,000 deaths from the virus, according to data from Johns Hopkins University.

The grim figure comes after another violent round of surging of infections, hospitalizations and deaths fueled by the highly transmissible Delta variant and largely driven by unvaccinated people.
The toll means the US continues to have more Covid-19 deaths than any other the country in the world, with Brazil, which has the second-highest number, reporting more than 597,000 deaths while India, third, reporting more than 448,000 deaths.

Comments

Post a Comment

Popular posts from this blog

Merck’s COVID-19 pill is a 'huge game changer': Doctor

  Dr. Anthony Harris, WorkCare chief innovation officer and associate medical director, joins the Yahoo Finance Live panel to discuss the latest coronavirus developments. Video Transcript SEANA SMITH: We want to bring in Dr. Anthony Harris, WorkCare chief innovation officer and associate medical director. Dr. Harris, it's good to see you. Let's start with the Merck news that they're planning to seek emergency use authorization for the treatment. How big of a game changer is this potentially just in terms of getting the pandemic under control? ANTHONY HARRIS: Thank you, Seana. A huge game changer, right? In terms of being able to prevent what we all know is the major risk factor, which is mortality-- death from the virus itself and hospitalization. And so, what we see with Merck is very compelling data, so much so that they stopped recruitment of the study in the phase two, phase three clinical trials because we were seeing such a dramatic effect at preventin...
Read more

Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector

Image
  By Lewis Krauskopf and Manojna Maddipatla (Reuters) - Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the healthcare sector on Friday, sending the drugmaker's stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies. Merck shares jumped as much as 12.3% and hit their highest level since February 2020 after data showed the company's pill molnupiravir https://www.reuters.com/business/healthcare-pharmaceuticals/mercks-covid-19-pill-cuts-risk-death-hospitalization-by-50-study-2021-10-01 could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19. Experts hailed the news as potentially a huge advance in the fight against COVID-19. At the same time, shares of vaccine makers such as Moderna Inc, Pfizer Inc and partner BioNTech SE were hit, with some analysts saying the promise of an oral dr...
Read more